NCCN Categories of Evidence and Consensus
Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2A: Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2B: Based upon lower-level evidence, there is NCCN consensus that the intervention is appropriate.
Category 3: Based upon any level of evidence, there is major NCCN disagreement that the intervention is appropriate.
All recommendations are category 2A unless otherwise noted.
Clinical trials: NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged.
FerrisFDBrueraEChernyN. Palliative cancer care a decade later: accomplishments, the need, next steps—from the American Society of Clinical Oncology. J Clin Oncol2009;27:3052–3058.
SeowHBarberaLSutradharR. Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol2011;29:1151–1158.
PeppercornJMSmithTJHelftPR. American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol2011;29:755–760.
ElsayemASwintKFischMJ. Palliative care inpatient service in a comprehensive cancer center: clinical and financial Outcomes. J Clin Oncol2004;22:2008–2014.
NHPCO Facts and Figures: Hospice Care in America. 2011 Edition. National Hospice and Palliative Care Organization. Available at: http://www.nhpco.org/files/public/Statistics_Research/2011_Facts_Figures.pdf. Accessed March 2 2012.
EarleCCLandrumMBSouzaJM. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?J Clin Oncol2008;26:3860–3866.
A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA1995;274:1591–1598.
SmithTJTeminSAlesiER. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol2012;30:880–887.
TemelJSGreerJAMuzikanskyA. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med2010;363:733–742.
GreerJAPirlWFJacksonVA. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol2012;30:394–400.
TemelJSGreerJAAdmaneS. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol2011;29:2319–2326.
GoelzTWuenschAStubenrauchS. Specific training program improves oncologists’ palliative care communication skills in a randomized controlled trial. J Clin Oncol2011;29:3402–3407.
BussMKLessenDSSullivanAM. Hematology/oncology fellows’ training in palliative care: results of a national survey. Cancer2011;117:4304–4311.
National Consensus Project for Quality Palliative Care. Clinical Practice Guidelines for Quality Palliative CareSecond Edition. Available at: http://www.nationalconsensusproject.org/guideline.pdf. Accessed August 23 2012.
National Quality Forum: A National Framework and Preferred Practices for Palliative and Hospice Care Quality. Available at: http://www.qualityforum.org/Publications/2006/12/A_National_Framework_and_Preferred_Practices_for_Palliative_and_Hospice_Care_Quality.aspx. Accessed August 23 2012.
QaseemASnowVShekelleP. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med2008;148:141–146.
Improving supportive and palliative care for adults with cancer. National Institute for Health and Clinical Excellence. Available at: www.nice.org.uk/page.aspx?o=csgsp. Accessed August 23 2012.
Cancer Program Standards 2012: Ensuring Patient-Centered Care. American College of Surgeons Commission on Cancer. Available at: http://www.facs.org/cancer/coc/cocprogramstandards2012.pdf. Accessed March 1 2012.
WeeksJCCookEFO’DaySJ. Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA1998;279:1709–1714.
LoBRustonDKatesLW. Discussing religious and spiritual issues at the end of life: a practical guide for physicians. JAMA2002;287:749–754.
GuarneriVContePF. The curability of breast cancer and the treatment of advanced disease. Eur J Nucl Med Mol Imaging2004;31(Suppl 1):S149–161.
PrommerE. Guidelines for the use of palliative chemotherapy. AAHPM Bulletin2004;5:2–13. Available at: http://www.aahpm.org/pdf/04spring.pdf. Accessed August 23 2012.
BrownJThorpeHNappV. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J Clin Oncol2005;23:7417–7427.
SilvestriGARiveraMP. Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest2005;128:3975–3984.
HigginsonIJFinlayIGGoodwinDM. Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?J Pain Symptom Manage2003;25:150–168.
KinzbrunnerBM. Hospice: what to do when anti-cancer therapy is no longer appropriate, effective, or desired. Semin Oncol1994;21:792–798.
TemelJSPirlWFLynchTJ. Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer. Clin Lung Cancer2006;7:241–249.
Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med1999;159:321–340.
DySMLorenzKANaeimA. Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. J Clin Oncol2008;26:3886–3895.
SwansonNMirzaIWijesingheNDevlinG. Primary percutaneous balloon pericardiotomy for malignant pericardial effusion. Catheter Cardiovasc Interv2008;71:504–507.
XueDAbernethyAP. Management of dyspnea in advanced lung cancer: recent data and emerging concepts. Curr Opin Support Palliat Care2010;4:85–91.
Ben-AharonIGafter-GviliAPaulM. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol2008;26:2396–2404.
ClemensKEQuednauIKlaschikE. Is there a higher risk of respiratory depression in opioid-naive palliative care patients during symptomatic therapy of dyspnea with strong opioids?J Palliat Med2008;11:204–216.
SimonSTHigginsonIJBoothS. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev2010:CD007354.
BackINJenkinsKBlowerABeckhellingJ. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med2001;15:329–336.
WildiersHDhaenekintCDemeulenaereP. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J Pain Symptom Manage2009;38:124–133.
#109 Death Rattle and Oral Secretions2nd ed.End of Life/Palliative Education Resource Center (EPERC). Available at: http://www.eperc.mcw.edu/fastFact/ff_109.htm. Accessed April 20 2012.
JensenDAlsuhailAViolaR. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease. J Pain Symptom Manage2012;43:706–719.
GalbraithSFaganPPerkinsP. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage2010;39:831–838.
MackJWCroninATabackN. End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med2012;156:204–210.
WrightAAKeatingNLBalboniTA. Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers’ mental health. J Clin Oncol2010;28:4457–4464.
ElsayemASmithMLParmleyL. Impact of a palliative care service on in-hospital mortality in a comprehensive cancer center. J Palliat Med2006;9:894–902.
KhatcheressianJCasselJBLyckholmL. Improving palliative and supportive care in cancer patients. Oncology (Williston Park)2005;19:1365–1376; discussion 1377–1368 1381–1362 1384 passim.
HughesTSchumacherMJacobs-LawsonJMArnoldS. Confronting death: perceptions of a good death in adults with lung cancer. Am J Hosp Palliat Care2008;25:39–44.
SteinhauserKEChristakisNAClippEC. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA2000;284:2476–2482.
GuldinMBVedstedPZachariaeR. Complicated grief and need for professional support in family caregivers of cancer patients in palliative care: a longitudinal cohort study. Support Care Cancer2012;20:1679–1685.
ZhangBEl-JawahriAPrigersonHG. Update on bereavement research: evidence-based guidelines for the diagnosis and treatment of complicated bereavement. J Palliat Med2006;9:1188–1203.
NajjarNDavisLWBeck-CoonKCarney DoebbelingC. Compassion fatigue: a review of the research to date and relevance to cancer-care providers. J Health Psychol2009;14:267–277.